Monthly Archives: July 2007

Hundreds of thousands of babies around the world are born each year with HIV ? more than half a million in 2006 alone. Caring for these children is complicated by the fact that their immune systems are not fully developed in the first year of life, which makes them especially susceptible to rapid HIV disease progression and death.
Continue reading →

Using a quantitative high-throughput screening strategy, researchers at the National Institutes of Health (NIH) have identified three new classes of small molecules that may prove useful for treating Gaucher disease, an inherited disorder that disrupts a cell’s ability to break down and dispose of certain cellular waste products. The findings, reported in the online edition of the Proceedings of the National Academy of Sciences during the week of July 23-27, could lead to a new therapeutic approach in which a defective enzyme is corrected by an easy-to-take oral medication.
Continue reading →

Using a quantitative high-throughput screening strategy, researchers at the National Institutes of Health (NIH) have identified three new classes of small molecules that may prove useful for treating Gaucher disease, an inherited disorder that disrupts a cell’s ability to break down and dispose of certain cellular waste products. The findings, reported in the online edition of the Proceedings of the National Academy of Sciences during the week of July 23-27, could lead to a new therapeutic approach in which a defective enzyme is corrected by an easy-to-take oral medication.
Continue reading →

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work. While ketamine itself probably won’t come into use as an antidepressant because of its side effects, the new finding moves scientists considerably closer to understanding how to develop faster-acting antidepressant medications – among the priorities of the National Institute of Mental Health (NIMH), part of the National Institutes of Health.
Continue reading →

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work. While ketamine itself probably won’t come into use as an antidepressant because of its side effects, the new finding moves scientists considerably closer to understanding how to develop faster-acting antidepressant medications – among the priorities of the National Institute of Mental Health (NIMH), part of the National Institutes of Health.
Continue reading →

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work. While ketamine itself probably won’t come into use as an antidepressant because of its side effects, the new finding moves scientists considerably closer to understanding how to develop faster-acting antidepressant medications – among the priorities of the National Institute of Mental Health (NIMH), part of the National Institutes of Health.
Continue reading →

The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will initially provide $9.5 million over three years to launch a Translational Research Network that will increase the opportunity for multi-site clinical and translational research among minority and other collaborating institutions throughout the nation. Investigators at these institutions are focused on cancer, diabetes, renal disease, infant mortality, HIV/AIDS, and cardiovascular diseases, diseases that disproportionately affect minority populations.
Continue reading →

The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will initially provide $9.5 million over three years to launch a Translational Research Network that will increase the opportunity for multi-site clinical and translational research among minority and other collaborating institutions throughout the nation. Investigators at these institutions are focused on cancer, diabetes, renal disease, infant mortality, HIV/AIDS, and cardiovascular diseases, diseases that disproportionately affect minority populations.
Continue reading →

The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will initially provide $9.5 million over three years to launch a Translational Research Network that will increase the opportunity for multi-site clinical and translational research among minority and other collaborating institutions throughout the nation. Investigators at these institutions are focused on cancer, diabetes, renal disease, infant mortality, HIV/AIDS, and cardiovascular diseases, diseases that disproportionately affect minority populations.
Continue reading →

Middle-aged adults who drank more than one soft drink daily, either diet or regular, have a more than 40 percent greater rate of either having or developing metabolic syndrome, a cluster of conditions that increase the risk for heart disease, according to new data from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Continue reading →